 | • レポートコード：MRC2106A022 • 出版社/出版日：Mordor Intelligence / 2021年5月20日 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、トラック・トレースソリューションの世界市場について調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（ハードウェアシステム、ソフトウェアソリューション）分析、技術別（バーコード、RFID）分析、用途別（シリアル化ソリューション、集約ソリューション）分析、エンドユーザー別（製薬会社、医療機器会社、その他）分析、地域別分析、競争状況、市場機会・未来動向などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・トラック・トレースソリューションの世界市場規模：製品別（ハードウェアシステム、ソフトウェアソリューション） ・トラック・トレースソリューションの世界市場規模：技術別（バーコード、RFID） ・トラック・トレースソリューションの世界市場規模：用途別（シリアル化ソリューション、集約ソリューション） ・トラック・トレースソリューションの世界市場規模：エンドユーザー別（製薬会社、医療機器会社、その他） ・トラック・トレースソリューションの世界市場規模：地域別 ・競争状況 ・市場機会・未来動向 |
The Track and Trace Solutions market is valued at approximately USD 2,056 million in 2020 and expected to reach USD 4,338.5 million in 2026, registering a CAGR of 13.1 % over the forecast period.
With the development in the COVID-19 vaccine and the various treatment and diagnostic devices and instruments to curb the pandemic, the risk of counterfeit drugs and diagnostic devices has increased in the world which has impacted positively on the pharmacy automation market. In March and April 2020, Homeland Security in the United States also notified 19,000 suspects of COVID-19-related domain names and seized over USD 3.2 million linked to 494 shipments of mislabeled, fraudulent, unauthorized, or prohibited COVID-19 test kits, treatment kits, homeopathic remedies, purported antiviral products, and PPE, which further led to 11 arrests. Such instances are expected to drive the adoption of track and trace solutions.
The major factors propelling the growth of the track and trace solutions market include growth in the medical devices and pharmaceutical industries, an increase in implementation of serialization, a rise in the number of packaging-related product recalls, and an increasing number of counterfeit drugs.
Drug counterfeiting is one of the major problems in large-scale pharmaceutical and biopharmaceutical companies. As per the article published by World Health Organization in 2019, about 1 out of 10 medical products that circulate in low- and middle-income countries are found to be substandard or falsified. This factor, consequently, is driving the adoption of track and trace solutions among drug manufacturers and other end users. Furthermore, in December 2020, the Janssen Pharmaceutical, a subsidiary of Johnson & Johnson notified that counterfeit SYMTUZA (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide) has been distributed to over three pharmacies in the United States. Janssen is currently working closely with the United States Food and Drug Administration (FDA) to prevent further distribution and to support the Agency’s investigation into the reported instances. Hence, these factors are expected to fuel the market growth.
However, factors, such as high costs associated with serialization and aggregation and lack of common standards for serialization and aggregation may hinder the market growth.
Key Market Trends
RFID Technology is Expected to Observe a Good Growth in the Track and Trace Solutions Market
The outbreak of COVID-19 has accelerated digitization and thereby the usage of RFID technology in healthcare has bolstered in the year 2020. These technologies are being used in tracking and authenticating vaccines, diagnostic kits, and others. For instance, in June 2020, the United States Department of Health and Human Services, Department of Defence, and ApiJect Systems America have gone under partnership for projects ”Project Jumpstart” and “RAPID USA,” for expanding syringe production and RFID technology could be affixed in these syringes. Hence, this is expected to support the market growth in this segment due to the COVID-19 situation.
Radio-frequency identification (RFID) technology also plays a stellar role in inventory management and supply-chain operations, as it improves both security and product handling. It also reduces the labor and time required for product handling in the supply chain. It has a huge role in tracking and tracing prescription drugs and reducing billions in costs from the medical and healthcare industry.
As a result, companies are now adopting RFID technology in the production and packaging process. In September 2020, Fresenius Kabi incorporated RFID-tag-equipped labels on medications such as prefilled syringes and vials which are commonly used in operating rooms in order to enhance the workflow of inventory management. The benefits of using modern and advanced RFID have increased its adoption and acceptance in the healthcare sector, which is the key factor for boosting the growth of the RFID segment.
North America is Expected to Dominate the Market Over the Forecast Period
North America currently dominates the market for track and trace solutions and is expected to continue its stronghold over the forecast period. In the North American region, the United States holds the largest share of the market. Due to the outbreak of COVID-19, the demand for track and trace solutions have fuelled in this region. For instance, in December 2020, Moderna a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines in order to develop a new generation of transformative medicines for patients notified that Moderna is currently running SAP Digital Supply Chain solutions to help with the serialization and distribution of a potential COVID-19 vaccine. The company currently has mRNA-1273, a vaccine candidate against COVID-19. Therefore, a positive impact is expected on the market studied due to COVID-19.
The primary factor attributing to the market growth is the increasing number of counterfeit drugs; due to the increasing number of counterfeit medicines available in the market, in 2019, Food & Drug Administration launched a new pilot project to inform the development of a new electronic, interoperable track-and-trace system, anticipated for 2023, as part of the Drug Supply Chain Security Act (DSCSA). This new system will be aimed at reducing incorrect domestic drug distribution and keeping counterfeit drugs from potentially entering the supply chain. The DSCSA pilot program focuses on identifying efficient processes which will comply with the requirements of drug supply chain security and technology for disseminating information.
Furthermore, according to United States Food and Drug Administration (FDA) ,the number of drug recall enforcement issued in the United States was 2,163 in 2019. Also, in July 2019, United States Food & Drug Administration recalled the CapsoCam Plus video capsule system of Capso Vision Inc., due to the mis-labeling of the device with incorrect serial number labels, which may have resulted in a patient’s misdiagnosis. Such instances have prompted the United States-based medical devices companies to adopt track and trace solutions.
Moreover, innovative solutions into track and tracing has also boosted the market growth in this region. For instance, in June 2020, Zebra Technologies Corp. launched Zebra MotionWorks Proximity that is featured with proximity sensing at user-level that enables alerting and contact tracing. This will provide a way to hospitals and other organizations to protect their employees’ health while in the work environment. This new product launch by the company will increase its credibility in the market. Therefore, with all the above mentioned factors, the market studied is expected to propel during the forecast period.
Competitive Landscape
The track and trace solutions market is competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising awareness about track and trace solutions and improving healthcare infrastructure, few other smaller players are expected to enter into the market. Some of the major players of the market are Axway, Mettler-Toledo International Inc., Rfxcel Corporation, Sea vision SRL and TraceLink Inc. among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in the Medical Devices and Pharmaceutical Industries and Increase in Implementation of Serialization
4.2.2 Rise in the Number of Packaging-related Product Recalls
4.2.3 Increasing Number of Counterfeit Drugs
4.3 Market Restraints
4.3.1 High Costs Associated with Serialization and Aggregation
4.3.2 Lack of Common Standards for Serialization and Aggregation
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Hardware Systems
5.1.1.1 Printing and Marking Solutions
5.1.1.2 Monitoring and Verification Solutions
5.1.1.3 Labeling Solutions
5.1.1.4 Other Hardware Systems
5.1.2 Software Solutions
5.1.2.1 Plant Manager Software
5.1.2.2 Line Controller Software
5.1.2.3 Bundle Tracking Software
5.1.2.4 Other Software Solutions
5.2 By Technology
5.2.1 Barcode
5.2.2 RFID
5.3 By Application
5.3.1 Serialization Solutions
5.3.1.1 Bottle Serialization
5.3.1.2 Label Serialization
5.3.1.3 Carton Serialization
5.3.1.4 Data Matrix Serialization
5.3.2 Aggregation Solutions
5.3.2.1 Bundle Aggregation
5.3.2.2 Case Aggregation
5.3.2.3 Pallet Aggregation
5.4 By End User
5.4.1 Pharmaceutical Companies
5.4.2 Medical Device Companies
5.4.3 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ACG
6.1.2 Adents
6.1.3 ANTARES VISION SpA
6.1.4 Axway
6.1.5 Mettler-Toledo International Inc.
6.1.6 Rfxcel Corporation
6.1.7 Optel Group
6.1.8 SEIDENADER MASCHINENBAU GMBH (MEDIPAK SYSTEMS)
6.1.9 Sea Vision SRL
6.1.10 TraceLink Inc.
6.1.11 Syntegon Technology GmbH
6.1.12 Zetes
6.1.13 Kezzler AS
6.1.14 Korber Medipak Systems GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS